EP0627930A4 - Composition and method of treating hepatitis b. - Google Patents

Composition and method of treating hepatitis b.

Info

Publication number
EP0627930A4
EP0627930A4 EP93917072A EP93917072A EP0627930A4 EP 0627930 A4 EP0627930 A4 EP 0627930A4 EP 93917072 A EP93917072 A EP 93917072A EP 93917072 A EP93917072 A EP 93917072A EP 0627930 A4 EP0627930 A4 EP 0627930A4
Authority
EP
European Patent Office
Prior art keywords
composition
treating hepatitis
hepatitis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93917072A
Other languages
German (de)
French (fr)
Other versions
EP0627930A1 (en
Inventor
Kenneth E Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0627930A1 publication Critical patent/EP0627930A1/en
Publication of EP0627930A4 publication Critical patent/EP0627930A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP93917072A 1992-07-13 1993-07-09 Composition and method of treating hepatitis b. Withdrawn EP0627930A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91467392A 1992-07-13 1992-07-13
US914673 1992-07-13
PCT/US1993/006485 WO1994001125A1 (en) 1992-07-13 1993-07-09 Composition and method of treating hepatitis b

Publications (2)

Publication Number Publication Date
EP0627930A1 EP0627930A1 (en) 1994-12-14
EP0627930A4 true EP0627930A4 (en) 1997-08-20

Family

ID=25434648

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93917072A Withdrawn EP0627930A4 (en) 1992-07-13 1993-07-09 Composition and method of treating hepatitis b.

Country Status (6)

Country Link
EP (1) EP0627930A4 (en)
CN (1) CN1087829A (en)
AU (1) AU4671193A (en)
MX (1) MX9304209A (en)
WO (1) WO1994001125A1 (en)
ZA (1) ZA935055B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200952B1 (en) 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
CA2175337C (en) * 1993-11-05 2000-06-20 Paul B. Chretien Method and composition for treatment of patients having decompensated liver disease
US6199073B1 (en) 1997-04-21 2001-03-06 Ricoh Company, Ltd. Automatic archiving of documents during their transfer between a peripheral device and a processing device
US5939423A (en) * 1997-04-16 1999-08-17 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir
US6288033B1 (en) 1998-09-25 2001-09-11 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir
WO2010129947A2 (en) 2009-05-08 2010-11-11 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
GB2506086A (en) 2011-10-21 2014-03-19 Abbvie Inc Methods for treating HCV comprising at least two direct acting antiviral agent, ribavirin but not interferon
CA2811250C (en) 2011-10-21 2015-08-11 Abbvie Inc. Methods for treating hcv
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
CN103494769B (en) * 2013-10-08 2015-12-23 深圳翰宇药业股份有限公司 A kind of compound long-acting in-situ gel injection agent for the treatment of chronic viral hepatitis B and preparation method thereof
US11192914B2 (en) 2016-04-28 2021-12-07 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
CN111450240A (en) * 2020-04-27 2020-07-28 浙江大学 Application of combination of small molecule compound M L N4924 and IFN α in anti-HBV

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357571A2 (en) * 1988-06-10 1990-03-07 Medivir Aktiebolag Pyrimidine nucleosides
WO1993005806A1 (en) * 1991-09-13 1993-04-01 Alpha 1 Biomedicals, Inc. Composition and method of treating hepatitis c
WO1996000573A1 (en) * 1994-06-30 1996-01-11 Bio-Logic Research And Development Corporation Compositions for enhancing immune function

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357571A2 (en) * 1988-06-10 1990-03-07 Medivir Aktiebolag Pyrimidine nucleosides
WO1993005806A1 (en) * 1991-09-13 1993-04-01 Alpha 1 Biomedicals, Inc. Composition and method of treating hepatitis c
WO1996000573A1 (en) * 1994-06-30 1996-01-11 Bio-Logic Research And Development Corporation Compositions for enhancing immune function

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9401125A1 *

Also Published As

Publication number Publication date
EP0627930A1 (en) 1994-12-14
CN1087829A (en) 1994-06-15
MX9304209A (en) 1994-04-29
ZA935055B (en) 1995-04-13
AU4671193A (en) 1994-01-31
WO1994001125A1 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
ZA947354B (en) Composition and process for treating metal
AP9300598A0 (en) Compositions and method for waste treatment
EP0717592A4 (en) Method and composition for the treatment of apathy-amotivation syndrome
ZA949346B (en) Composition and process for treating metal
EP0556447A3 (en) Surfactant composition and method of making the same
EP0579453A3 (en) Masonry treating composition and method.
EP0627930A4 (en) Composition and method of treating hepatitis b.
ZA931778B (en) Method and composition for the treatment of osteoporosis
ZA948252B (en) Method and composition for treatment of autoimmune hepatitis
GB9014307D0 (en) Method of treatment and compositions therefor
ZA932483B (en) Method and composition for treating acne
AU9087591A (en) Composition and method for treating metal
GB9224295D0 (en) Method and composition
EP0454169A3 (en) Photomask and method of treating the same
GB9202196D0 (en) Method of treatment
EP0611214A3 (en) Acidic composition and process of using same.
EP0717622A4 (en) Methods of treating hiv with azaspiranes
ZA939171B (en) Composition and process for treating tinplate
SG54220A1 (en) Composition and process for treating metal
CS61691A2 (en) Composition for dung-water treatment and method of dung-water treatment
AU5467198A (en) Composition and method of treating hepatitis B
GB9026896D0 (en) Method and composition
GB9201391D0 (en) Method of treatment
PL289358A1 (en) Posticide and method of treating soil therewith
GB9211591D0 (en) Method and composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19970703

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17P Request for examination filed

Effective date: 19940927

17Q First examination report despatched

Effective date: 19980401

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990223